Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 163.20
Bid: 163.20
Ask: 164.80
Change: 0.80 (0.49%)
Spread: 1.60 (0.98%)
Open: 162.00
High: 164.80
Low: 162.00
Prev. Close: 162.40
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 May 2023 07:00

RNS Number : 5737A
Sabre Insurance Group PLC
25 May 2023
 

25 May 2023

 

Sabre Insurance Group plc

Trading Update

Full year guidance reiterated

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the period from 1 January 2023 to 30 April 2023 ahead of its Annual General Meeting ("AGM") later this morning.

Unaudited

Unaudited

4 months ended

4 months ended

 

 30 Apr 2023

30 Apr 2022

Gross written premium - Motor

£47.9m

£45.3m

Gross written premium - Motorcycle

£6.3m

£12.0m

Gross written premium - Taxi

£4.7m

£2.5m(1)

Gross written premium - Total

£58.9m

£59.8m

(1) = Disclosed as part of 'Motor' in the May 2022 trading update

Business highlights for the first four months of 2023

‒ Gross written premium in Motor has increased year on year, with profitability in line with expectations and ahead of the same period last year

‒ Further progress in improving the profitability of the Motorcycle business with the current run-rate performance in-line with expectations and anticipated to deliver a positive contribution to profit in 2023

‒ Underwriting actions to improve the profitability of the Taxi business are anticipated to continue through 2023, reflected in current reduced premium run-rate of this business

‒ Ongoing focus on profitability, not volume, with total policy count of 275k as at 30 April 2023 (31 December 2022: 304k) including 54k motorcycle policies (31 December 2022: 74k) and 14k taxi policies (31 December 2022: 12k)

‒ Whilst core Motor policy count declined early in the year, we have seen a return to growth in policy count in recent weeks

‒ Post-dividend solvency capital ratio at 31 March 2023 of 172% (31 March 2022: 160%)

Market trends

‒ Claims inflation for 2023 anticipated to remain at c.10%, as previously guided

‒ Evidence of positive momentum in market pricing since late March, with this trend anticipated to continue in the coming months

Full year guidance reiterated

‒ High single-digit growth in overall gross written premium anticipated for the full year

‒ Low double-digit growth in core Motor business gross written premium somewhat offset by a reduction in the Motorcycle and Taxi businesses as underwriting actions take hold

‒ Combined operating ratio expected to be between 85% to 90%

‒ Expected expense ratio strain in H1, and improvements on loss ratios throughout 2023 as pricing actions earn through, means H1 combined operating ratio likely to be higher than the expected 2023 full year position

‒ Note that this guidance is carried forward from year-end on an IFRS4-equivalent basis

Geoff Carter, Chief Executive Officer of Sabre, commented:

"I am pleased to be able to continue my message of cautious optimism from our full-year results into our first update for 2023, and indeed I am feeling slightly more optimistic given strong volumes in recent weeks.

In particular, we have been encouraged by the trends that we have been seeing from mid-March and into May. There is clear evidence that market pricing is improving, and we have seen weekly gross written premiums across this period in our core Motor business over 20% higher than the same time last year. We anticipate this trend of improving market pricing will continue, albeit it is too early to tell what the pace and trajectory of improvement will be, and are confident in our ability to continue to grow volumes at the appropriate margin. We are currently in the fortunate position of making pricing decisions designed to find an optimal point between volume growth and margin enhancement.

We expect the loss ratios in the core Motor business to improve through the rest of 2023, with pricing actions reflecting ongoing inflation. Volumes for the Taxi business have been suppressed while this market segment remains challenging. The actions we took last year and this year to increase the profitability of the Motorcycle businesses should generate a positive contribution to profit.

If these positive market pricing trends and run-rates continue through the rest of the year, we anticipate a strong bounce-back in earnings compared to 2022."

 

Investor enquiries

01306 747 272

Sabre Insurance Group plc

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Teneo

sabre@teneo.com

James Macey White / Eleanor Pomeroy

 

LEI Code: 2138006RXRQ8P8VKGV98

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEMFALEDSEFI
Date   Source Headline
23rd Apr 20244:00 pmRNSHolding(s) in Company
22nd Apr 20243:22 pmRNSHolding(s) in Company
19th Apr 20248:51 amRNSChair Appointment
18th Apr 202411:22 amRNSDirector Declaration
11th Apr 202412:41 pmRNSDirector/PDMR Shareholding
11th Apr 202412:07 pmRNSDirector/PDMR Shareholding
9th Apr 20242:44 pmRNSDirector/PDMR Shareholding
5th Apr 20243:48 pmRNSNotice of AGM
21st Mar 202412:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFull-year results 2023
13th Mar 20249:33 amRNSNotice of Results
12th Mar 20242:16 pmRNSDirector/PDMR Shareholding
12th Mar 202412:14 pmRNSDirector Declaration
16th Feb 20241:52 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading Statement
13th Feb 20242:18 pmRNSDirector/PDMR Shareholding
11th Jan 202411:11 amRNSDirector/PDMR Shareholding
20th Dec 20232:24 pmRNSHolding(s) in Company
12th Dec 202312:03 pmRNSDirector/PDMR Shareholding
28th Nov 20234:27 pmRNSDirectorate Change
27th Nov 20234:42 pmRNSRemuneration Committee Chair Appointment
22nd Nov 20238:51 amRNSNotification of cyber incident
20th Nov 20237:00 amRNSDeath of Chair
13th Nov 202311:44 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSTrading Update
11th Oct 202312:52 pmRNSDirector/PDMR Shareholding
25th Sep 20233:39 pmRNSDirector/PDMR Shareholding
21st Sep 202311:48 amRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
13th Sep 20239:33 amRNSDirectorate Change
11th Aug 202310:07 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSHalf-year Report 2023
25th Jul 20238:53 amRNSDirector Declaration
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
13th Jun 202310:09 amRNSDirector/PDMR Shareholding
2nd Jun 20233:02 pmRNSDirector/PDMR Shareholding
25th May 202311:22 amRNSResult of AGM
25th May 20239:27 amRNSDirector/PDMR Shareholding
25th May 20237:01 amRNSBoard Appointment
25th May 20237:00 amRNSTrading Update
11th May 202311:42 amRNSDirector/PDMR Shareholding
18th Apr 20233:19 pmRNSDirector/PDMR Shareholding
12th Apr 202311:53 amRNSDirector/PDMR Shareholding
6th Apr 202312:28 pmRNSDirector/PDMR Shareholding
31st Mar 20233:43 pmRNSNotice of AGM
31st Mar 20233:37 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
13th Mar 202312:13 pmRNSDirector/PDMR Shareholding
13th Feb 20231:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.